Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,443,441
+$430,988 QoQ
Shares Held
13,684
-1.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,556
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. ABBV ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,810 | $334,772 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,443,441 | 13,684 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $3,012,453 | 13,851 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,179,438 | 13,915 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,188,537 | 13,771 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,562,669 | 13,806 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,022,954 | 14,428 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,559,768 | 14,405 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $2,825,741 | 14,309 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $2,350,681 | 13,705 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $2,501,507 | 13,737 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,337,391 | 8,630 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,757,864 | 11,793 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,592,104 | 11,817 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $1,914,033 | 12,010 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $1,762,195 | 10,904 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $1,445,710 | 10,772 | Shares | Sole | 2023-12-13 | |
| 2022-06-30 | $1,580,458 | 10,319 | Shares | Sole | 2023-12-13 | |
| 2022-03-31 | $1,692,752 | 10,442 | Shares | Sole | 2023-12-13 | |
| 2021-12-31 | $1,312,161 | 9,691 | Shares | Sole | 2023-12-13 | |
| 2021-09-30 | $1,034,365 | 9,589 | Shares | Sole | 2023-12-13 | |
| 2021-06-30 | $1,148,928 | 10,200 | Shares | Sole | 2023-12-13 | |
| 2021-03-31 | $1,052,655 | 9,727 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,004,316 | 9,373 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $838,323 | 9,571 | Shares | Sole | 2021-05-17 | |
| 2020-06-30 | $410,686 | 4,183 | Shares | Sole | 2021-05-18 | |
| 2020-03-31 | $276,036 | 3,623 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||